Patents Assigned to Respirion Pharmaceuticals PTY LTD
  • Method for reducing lung inflammation
    Patent number: 11491126
    Abstract: A method of treating or preventing inflammation in the lung by administering a high concentration of an inhaled chelating agent.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: November 8, 2022
    Assignee: Respirion Pharmaceuticals PTY LTD
    Inventor: Barry Clements
  • Method for reducing lung infection
    Patent number: 11382884
    Abstract: A method of treating or preventing a bacterial infection in the lung of a subject by administering an inhaled antibiotic, and at least 37.5 mg/day of an inhaled chelating agent, each in one or more doses, wherein the or each dose of the chelating agent and/or antibiotic is administered over a period of no more than 8h.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: July 12, 2022
    Assignee: Respirion Pharmaceuticals PTY LTD
    Inventor: Barry Clements